Top Markets
Coin of the day
Catalent, Inc. Catalent, Inc.

Catalent, Inc.

CTLT
Rang în acțiuni #1926
Catalent, Inc., operating globally through its various subsidiaries,... Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.
Preț acțiune
$63.48
Ultima sincronizare: 2024-12-17
Capitalizare de piață
$11.52B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Catalent, Inc. (CTLT)

Categorie

Număr de acțiuni în circulație pentru Catalent, Inc. (CTLT)
Număr de acțiuni în circulație la data de September 2024: 182.00M
Conform celor mai recente rapoarte financiare și prețului acțiunilor Catalent, Inc., numărul curent de acțiuni în circulație este 182.00M. La sfârșitul anului June 2023, compania avea 181.00M acțiuni în circulație. Numărul de acțiuni în circulație este de obicei influențat de splituri de acțiuni și programe de răscumpărare.
Istoricul acțiunilor în circulație pentru Catalent, Inc. (CTLT) din 2011 până în 2026
Acțiuni în circulație la sfârșitul fiecărui an
An Acțiuni în circulație Schimbă
2026 (TTM) 182.00M 0.55%
2024 181.00M 0.00%
2023 181.00M 2.84%
2022 176.00M 4.76%
2021 168.00M 12.15%
2020 149.79M 3.85%
2019 144.25M 9.94%
2018 131.20M 4.96%
2017 125.00M 0.16%
2016 124.80M 4.10%
2015 119.89M 2.20%
2014 117.30M -0.02%
2013 117.32M 0.00%
2012 117.32M 0.00%
2011 117.32M 0.00%
Acțiuni în circulație pentru companii similare sau concurente